Review Article
Management of High-Risk Localized Prostate Cancer
Table 3
Risk stratification for high-risk prostate cancer.
| Source | High-risk definition |
| D’Amico et al. [13] | Stage T2c or PSA > 20 ng/mL or Gleason > 8 | RTOG 9902, 0521 [14, 15] | Any T stage, PSA 20–100 ng/mL, Gleason > 7 or stage ≥ T2, PSA < 100 ng/mL, Gleason 8–10 | NCCN (v1.2011) [16] | Stage ≥ T3 and/or PSA > 20 ng/mL and/or Gleason 8–10* |
|
|
Adapted from Nat Rev Urol 2010 Nature Publishing Group [17]. *Combines high-risk and very high risk (locally advanced) groups.
|